Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the completed fisogatinib Phase 1 study record, including its eligibility criteria, locations, and study outcomes, instead of a 403 error.
    Difference
    59%
    Check dated 2026-11-08T14:56:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision displayed in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:02:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A dismissible notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in response to an executive order.
    Difference
    1%
    Check dated 2026-10-25T16:53:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:27:02.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:44.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates that core study information is not accessible on the page.
    Difference
    17%
    Check dated 2026-09-20T20:31:03.000Z thumbnail image

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.